car-t cells in multiple myeloma
Published 4 years ago • 303 plays • Length 23:03Download video MP4
Download video MP3
Similar videos
-
23:41
ictc session 3a update on the results of car t cells in myeloma
-
44:36
anti-bcma bispecific antibody for myeloma relapse after car t cells
-
23:57
iach 2019: car t cell therapy - how to set up a clinical unit
-
49:25
therapy of relapsed multiple myeloma - an update
-
30:02
car-t cell therapy in lymphoma
-
56:37
management of multiple myeloma during covid 19
-
40:15
cd19 targeted car t cells in refractory systemic lupus erythematosus
-
0:42
talquetamab treatment in patients with r/r myeloma with prior exposure to t-cell-directed therapies
-
45:36
auto transplant vs chimeric antigen receptor t-cell therapy for relapsed dlbcl in partial remission
-
55:58
role of cd19 car t cells in second line large b cell lymphoma
-
54:11
car t-cells in lymphoma: new advances and practical aspects
-
26:11
iach 2019: multiple myeloma
-
47:52
gut microbiome correlates of response and toxicity following anti cd19 car t cell therapy
-
52:11
car-t cells in lymphoma: the latest data
-
51:16
bench at bedside models facilitate car-t cell supply chain
-
34:07
outcomes in patients treated w/ chimeric antigen receptor t-cell therapy admitted to intensive care
-
3:47
what is car t-cell therapy?
-
45:36
autologous transplant vs chimeric antigen rec. t-cell therapy for relapsed dlbcl in partial rem.
-
36:07
iach webinar series: anti-cd38 monoclonal antibodies in multiple myeloma